MissionIR Articles

pSivida is engaged in developing tiny, sustained-release drug delivery products created to deliver drugs at a controlled or steady rate for months or years. The company is currently focused on treating chronic diseases of the…

Sucampo Pharmaceuticals is a worldwide pharmaceutical company engaged in the innovative research, discovery, development and commercialization of proprietary drugs based on prostones. Sucampo Chairman, CEO and Co-founder Ryuji Ueno, M.D., Ph.D., was the first person…

Regulus Therapeutics is a biopharmaceutical company at the forefront of discovering and developing innovative medicines that target microRNAs. Leveraging a mature therapeutic platform that is based on technology developed over 20 years, the company is…

Protalix BioTherapeutics is a biopharmaceutical company engaged in developing and commercializing recombinant therapeutic proteins expressed through ProCellEx, a proprietary plant cell-based expression system. Using ProCellEx, the company is developing and commercializing a proprietary pipeline of…

Astex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of novel small molecule therapeutics, with a focus on oncology. The company is currently engaged in developing a proprietary pipeline of novel therapies…

NanoViricides is a development-stage company engaged in creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide class of drug candidates is designed for the specific purpose of attacking and dismantling enveloped virus particles.…

Prima BioMed is a biotechnology that is active throughout the world. A leader in personalized bio-therapeutic cancer products, the company is focused on leveraging its current technology and expertise in developing innovative treatment options for…

Synthetic Biologics is a biotechnology company developing product candidates for serious infections and diseases. The company is developing a biologic for preventing C. diff infection as well as a series of monoclonal antibodies (mAbs) for…

DURECT is a specialty pharmaceutical company focused on developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil. The company’s proprietary oral, transdermal and injectable depot delivery…

Tengion is a leading clinical-stage regenerative medicine company focused on the development of its pioneering Organ Regeneration Platform. This platform is intended to harness the body’s intrinsic regenerative pathways to regenerate an array of native-like…

Tekmira Pharmaceuticals is a biopharmaceutical company and a leader in developing RNA interference (RNAi) therapeutics. The company is focused on advancing novel RNAi therapeutics and supplying pharmaceutical partners with its leading lipid nanoparticle delivery technology.…

Nymox Pharmaceutical is focused on researching and developing novel drugs and diagnostic products for the aging population. NX-1207, the company’s lead drug candidate, is a proprietary treatment for enlarged prostate or benign prostatic hyperplasia (BPH)…

ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for treating various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications…

ACADIA Pharmaceuticals is a biopharmaceutical company with its focus on innovative treatments addressing unmet medical needs in neurological and related central nervous system disorders. Pimavanserin, which is in Phase III clinical development as a potential…

ZIOPHARM Oncology is a biopharmaceutical company engaged in developing and commercializing new cancer therapies. The company’s clinical programs include palifosfamide, currently being studied in two Phase 3 clinical trials; Ad-RTS IL-12, currently being tested in…

Apricus Biosciences is a biopharmaceutical company engaged in developing and marketing innovative treatments to help large patient populations across numerous high-demand therapeutic classes, including male and female sexual health. With three approved products, the company…

Affymax is a Palo Alto, Calif.-based biopharmaceutical company. The company’s focus is on discovering, developing and delivering innovative therapies to improve the lives of patients suffering with kidney disease and other serious, often life-threatening illnesses.…